Additional Recombinant COVID-19 Humoral and Cell-Mediated Immunogenicity in Immunosuppressed Populations

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT06027229

Recruitment Status : Suspended (slow accrual)

First Posted : September 7, 2023

Last Update Posted : May 10, 2024

View this study on the modernized ClinicalTrials.gov

Sponsor:

Collaborator:

Novavax

Information provided by (Responsible Party):

University of Wisconsin, Madison

Study Details
Tabular View
No Results Posted
Disclaimer
How to Read a Study Record

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Recruitment Status :	Suspended
Estimated Primary Completion Date :	March 2025
Estimated Study Completion Date :	March 2025

To Top